• 23. Januar 2025

Curetis Enters into Distribution Agreement to Expand Commercial Activities into Greater China

ByCuretis AG

Sep. 25, 2015
#8722 Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan
#8722 Clinical trials for CFDA regulatory approval in preparation

Teile den Beitrag mit Freunden